Selank is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.
Clinical noninferiority trial in 62 GAD patients showed similar anxiolytic action to medazepam (benzodiazepine). Multiple Russian clinical studies demonstrate efficacy. Evidence base predominantly from Russian institutions. Selank is not fda-approved. approved in russia (2009) for generalized anxiety disorder. available as research chemical in us.
What Does the Research Say About Selank?
Clinical noninferiority trial in 62 GAD patients showed similar anxiolytic action to medazepam (benzodiazepine). Multiple Russian clinical studies demonstrate efficacy. Evidence base predominantly from Russian institutions.
Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro heptapeptide) is a Nootropic anxiolytic peptide. Research interest has focused on its potential effects on anxiety reduction, cognitive enhancement, stress resilience, benzodiazepine-like anxiolysis without dependence.
What Is the Evidence for Selank's Mechanism?
Allosterically modulates GABAA receptors and inhibits enkephalin-degrading enzymes. Influences dopaminergic and serotonergic systems while enhancing GABA-mediated neurotransmission, producing anxiolytic effects comparable to benzodiazepines without receptor downregulation, tolerance, or dependence.
These pathways have been identified through in vitro studies, animal models, and where available, human trials.
Are There Human Clinical Trials for Selank?
Clinical noninferiority trial in 62 GAD patients showed similar anxiolytic action to medazepam (benzodiazepine). Multiple Russian clinical studies demonstrate efficacy. Evidence base predominantly from Russian institutions.
The gap between preclinical promise and clinical validation remains the biggest challenge in peptide research. However, Selank has shown encouraging results.
What Does the Safety Research Show?
Well-tolerated. Mild nasal irritation at application site. No amnesia, withdrawal, or dependence liability — unlike benzodiazepines.
Selank is not fda-approved. approved in russia (2009) for generalized anxiety disorder. available as research chemical in us.
What Makes Selank Unique in Research?
First anxiolytic peptide achieving benzodiazepine-equivalent action without any dependence, withdrawal, or amnesia — solving the fundamental safety limitation of the entire benzodiazepine drug class.
This differentiator is important because it means Selank fills a role that other compounds in its class may not fully replicate.
Bottom Line on Selank Research
The evidence base for Selank is growing. Key research areas include anxiety reduction, cognitive enhancement, stress resilience, benzodiazepine-like anxiolysis without dependence.
Stay current with PubMed searches for Selank for the latest publications.
Complete Guide
Selank: The Anxiolytic Research Peptide
Related Reading
- Selank Dosage Guide
- Selank Benefits
- Selank Side Effects
- Selank Stacking Guide
- Selank Cycle Guide
- Semax Complete Guide
Calculate Your Selank Dose
Use our free peptide dosing calculator to get exact reconstitution math and syringe units for Selank.
Open Calculator →Research-Grade Sourcing
If you're going to research Selank, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.
Frequently Asked Questions
What is Selank?
Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro heptapeptide) is a Nootropic anxiolytic peptide. Developed by the Institute of Molecular Genetics (Russian Academy of Sciences) as a benzodiazepine-like anxiolytic without sedation or dependence. It is researched for anxiety reduction, cognitive enhancement, stress resilience, benzodiazepine-like anxiolysis without dependence.
What is the recommended Selank dosage?
Common dosages: 75-300 mcg administered 1-3 times daily via intranasal spray. Cycle length: 5-21 days with washout periods. Half-life: not established. Use our peptide calculator for exact reconstitution math.
What are the side effects of Selank?
Well-tolerated. Mild nasal irritation at application site. No amnesia, withdrawal, or dependence liability — unlike benzodiazepines.
Is Selank safe?
Selank has shown a favorable safety profile in research. Not FDA-approved. Approved in Russia (2009) for generalized anxiety disorder. Available as research chemical in US. All research should follow appropriate safety protocols.